Literature DB >> 11156498

Methodology of clinical trials in hand osteoarthritis: conventional and proposed tools.

M G Lequesne1, E Maheu.   

Abstract

BACKGROUND: Although very common, hand osteoarthritis (OA) is rarely the focus of clinical trials aimed at determining whether a drug is effective on its symptoms and/or anatomical progression. Besides the common difficulties met in trials in OA in general, the highly unpredictable course of hand OA presents specific challenges. However, hand OA is beginning to be considered as a potential model for the study of drugs in OA, since researchers now have at their disposal new clinical tools and radiological methods to assess with better accuracy and sensitivity either its symptomatic activity or its anatomical course.
METHOD: The now well-known consensual recommendations for the design and conduct of clinical trials in OA are reviewed, and the specific clinical tools and radiological methods available for the assessment of hand OA detailed. Some specific recommendations for the design of clinical trials in hand OA and the selection of patients for such trials are proposed, taking into account the particularities of this location of OA.

Entities:  

Mesh:

Year:  2000        PMID: 11156498     DOI: 10.1053/joca.1999.0340

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  3 in total

1.  Performance of global assessments of hip, knee, and back symptom change.

Authors:  Kelli D Allen; Joanne M Jordan; Michael Doherty; Jordan B Renner; Virginia B Kraus
Journal:  Clin Rheumatol       Date:  2010-08-04       Impact factor: 2.980

2.  Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study.

Authors:  Reto Widrig; Andy Suter; Reinhard Saller; Jörg Melzer
Journal:  Rheumatol Int       Date:  2007-02-22       Impact factor: 2.631

3.  The normal hip joint space: variations in width, shape, and architecture on 223 pelvic radiographs.

Authors:  M Lequesne; J Malghem; E Dion
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.